News & Media

IBA News & Media Room

Spacer

Filter by media type:

Filter by media category:

Filter by date created:

Spacer

White papers

20.12.2020

Proton therapy

IBA proton therapy clinical references

EN

>

White papers

20.12.2020

Proton therapy

IBA white paper: Treating Hodgkin and non-Hodgkin lymphoma with proton therapy

EN

>

White papers

20.12.2020

Proton therapy

IBA white paper: Treating head and neck cancer with proton therapy

EN

>

Press release

17.12.2020

Proton therapy

IBA demonstrates its commitment to its customers by upgrading two Proteus centers with Cone Beam CT state of the art imaging system

EN

>

Press release

27.11.2020

Proton therapy

IBA highlights how its Proteus solutions and network of clinical and industrial partners are shaping the future of Proton Therapy at ESTRO 2020 Annual Congress

EN

>

Press release

28.10.2020

Proton therapy

IBA is referenced by Unicancer for three years on the Proton Therapy Market within its network

EN

FR

>

Press release

23.10.2020

Proton therapy

IBA Highlights the Future of Proton Therapy Technologies and the power of its network of partners at ASTRO 2020 Annual Meeting

EN

>

Press release

25.09.2020

Proton therapy

100,000 Patients Treated With IBA Proton Therapy Technology

EN

FR

>

Press release

24.09.2020

Proton therapy

First payment of EUR 20 million received for strategic licensing deal in China

EN

FR

>

Press release

16.09.2020

Proton therapy

First Patients Treated with Proton Therapy in Belgium

EN

FR

NL

>

Press release

01.09.2020

Proton therapy

IBA signs contract for Proteus®PLUS Proton Therapy Solution in Chengdu, Sichuan Province, China

EN

FR

>

Press release

26.08.2020

Proton therapy

IBA announces strategic licensing deal for Proteus®PLUS in China worth a minimum of EUR 100 million

EN

FR

CN

>

1 of 2
next ›

Cookies policy

En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et des offres adaptés à vos centres d’intérêts.